Le Gouill S, Morschhauser F, Chiron D, Bouabdallah K, et al. Ibrutinib, Obinutuzumab And Venetoclax In Relapsed and Untreated Patients with Mantle-Cell Lymphoma, a phase I/II trial. Blood 2020 Nov 12. pii: 474141. doi: 10.1182/blood.2020008727.
PMID: 33181832